Author:
Cappuzzo F.,Toschi L.,Tallini G.,Ceresoli G.L.,Domenichini I.,Bartolini S.,Finocchiaro G.,Magrini E.,Metro G.,Cancellieri A.,Trisolini R.,Crino L.,Bunn P.A.,Santoro A.,Franklin W.A.,Varella-Garcia M.,Hirsch F.R.
Reference60 articles.
1. Cancer Statistics, 2001
2. Erlotinib in previously treated non-small cell lung cancer;Shepherd;N Engl J Med,2005
3. Randomized phase II/III Trial of paclitaxel (P) plus carboplatin (C) with or without bevacizumab (NSC # 704865) in patients with advanced non-squamous non-small cell lung cancer (NSCLC) An Eastern Cooperative Oncology Group (ECOG) Trial E4599;Sandler;Proc Am Soc Clin Oncol,2005
4. The erbB family of receptors and their ligands: multiple targets for therapy;Salomon;Signal,2001
5. Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia;Arteaga;Sem Oncol,2002
Cited by
87 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献